What is Healogics?
Established in 1996 and headquartered in Jacksonville, Florida, Healogics operates as a premier provider of advanced wound care services. The company specializes in the clinical management of chronic wounds, including diabetic ulcers, surgical wounds, venous ulcers, pressure ulcers, trauma wounds, and arterial ulcers. By integrating evidence-based medicine with specialized clinical expertise, Healogics provides a comprehensive care continuum that improves patient quality of life while reducing the overall cost of care for healthcare systems. Their market position is defined by a robust network of outpatient wound care centers, which serve as a vital resource for patients suffering from non-healing wounds that require specialized intervention beyond traditional primary care settings.
How much funding has Healogics raised?
Healogics has raised a total of $165M across 1 funding round:
Private Equity
$165M
Private Equity (2021): $165M with participation from Marathon Asset Management
Key Investors in Healogics
Marathon Asset Management
A global investment management firm that specializes in credit and fixed-income strategies, providing capital to mature companies seeking to optimize their financial structures.
Undisclosed Institutional Partner
An undisclosed investor participating in the funding round, contributing to the strategic growth of the enterprise.
Undisclosed Private Equity Firm
An undisclosed investor participating in the funding round, focusing on long-term value creation in the healthcare services sector.
What's next for Healogics?
With this major strategic investment, Healogics is poised to accelerate its growth trajectory through both organic expansion and the optimization of its existing clinical assets. The company is expected to focus on digital health integration, potentially enhancing its telehealth capabilities to reach a broader patient demographic. Furthermore, the capital will likely support the refinement of its data-driven clinical decision support tools, which are essential for maintaining high standards of care in the treatment of chronic conditions. As the company moves into its next phase of development, the focus will remain on scaling its operational efficiency and solidifying its status as the standard-bearer for wound care excellence in the enterprise healthcare market.
See full Healogics company page
